Results for
"[search-keyword]"
Sponsor content
811 result(s) found, displaying 211 to 220
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIP bevacizumab 400 mg/16 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BEVACIPTIN bevacizumab 100 mg/4 mL concentrated solution for infusion vial.
-
Prescription medicine registrationActive ingredients: Salmeterol xinafoate, Fluticasone propionate.
-
Prescription medicine decision summaryTGA decision: Ciptunec Ardalicip (adalimumab) is approved to treat arthritis.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO CIPHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
Prescription medicine decision summaryTGA decision: Filpegla (pegfilgrastim) is approved for the treatment of cancer patients following chemotherapy.
-
Prescription medicine registrationActive ingredients: Adalimumab.
-
Prescription medicine registrationActive ingredients: Pegfilgrastim.